Organogenesis Holdings (ORGO) EPS (Basic) Growth (1y) (2017 - 2026)
Organogenesis Holdings (ORGO) EPS (Basic) Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 68.42% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 5.97% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -11.98% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 2,362.50% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -883.55% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -21.43% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -385.71% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 72.64% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 233.33% |
| 10 | Organogenesis Holdings | 300.96 Mn | 208.86 Mn | 11.46 Mn | -158.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -158.82% |
| Dec 31, 2025 | 600.00% |
| Sep 30, 2025 | 22.22% |
| Jun 30, 2025 | 23.08% |
| Mar 31, 2025 | -750.00% |
| Dec 31, 2024 | 1,024.16% |
| Sep 30, 2024 | 350.00% |
| Jun 30, 2024 | -425.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -107.21% |
| Sep 30, 2023 | 1,117.70% |
| Jun 30, 2023 | -42.86% |
| Mar 31, 2023 | -100.00% |
| Dec 31, 2022 | -84.62% |
| Sep 30, 2022 | -98.36% |
| Jun 30, 2022 | -56.25% |
| Mar 31, 2022 | -112.50% |
| Dec 31, 2021 | 129.41% |
| Sep 30, 2021 | -50.00% |
| Jun 30, 2021 | 420.00% |